Intellectual Property
Read how the US Court of Appeals for the Federal Circuit affirms a rejection of patent claims for cancer drug dosing, emphasizing that inventor motivation isn’t required to prove obviousness.
Learn more about Thomson Reuters v. Ross Intelligence and its implications for AI training data and copyright law. The decision is a significant development for companies building or deploying AI systems that rely on third-party content.
A pivotal ruling in pharmaceutical patent litigation restricts Orange Book entries to active ingredients, raising antitrust litigation concerns for drug companies.
A US appeals court rules that AI-generated artwork cannot be copyrighted, reaffirming that human authorship is required under the Copyright Act of 1976.
Legal battles over AI and fair use of copyrighted material are shaping the future as creators push for stronger protections.
Learn more about recent lawsuits, which set major precedents for AI copyright law and sparked debates on fair use and the future of AI-generated content in 2025.
The Patent Trial and Appeal Board (PTAB) denied Aylo Freesites’ second petition, ruling that it failed to justify multiple IPR filings against the same patent.
Explore the DeepSeek US trademark battle as Delson Group claims prior rights, highlighting the risks of late filings and the complexities of trademark law.
Read how the US Copyright Office has clarified that AI-generated content can receive copyright protection if a human substantially contributes to or modifies it.
The surge in GenAI patent applications means it will likely become more difficult to obtain new GenAI patents going forward. Learn about the best way for legal departments to boost their chances of securing patents linked to the fast-evolving technology.
Daily Updates
Sign up for our free daily newsletter for the latest news and business legal developments.
